Intramuscular (IM) B12 injections using hydroxocobalamin, the preferred licensed form in the UK are recommended when: Oral supplementation has failed to correct a documented deficiency The patient has difficulty adhering to daily oral regimens Serum B12 levels remain persistently low despite adequate oral dosing There is clinical evidence of neurological or haematological complications In line with BNF guidance, the standard IM regimen for confirmed deficiency without neurological involvement is a loading course of 1 mg hydroxocobalamin on alternate days for two weeks , followed by maintenance of 1 mg every three months
Boost your skin's condition and achieve multiple benefits with this serum
20 Peptide-based therapeutics offer distinct advantages over conventional drugs, including high target specificity, enhanced safety profiles with minimal off-target effects, and low immunogenicity
However, studies on the application of the LNP-mRNA system for the treatment of pulmonary fibrosis are lacking
EBioMedicine 2017, 21, 131141
Safety & Tolerability Generally well tolerated in preclinical and cosmetic research
